Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 7 studies | 33% ± 10% | |
| mesothelial cell | 6 studies | 60% ± 17% | |
| astrocyte | 5 studies | 56% ± 20% | |
| chondrocyte | 4 studies | 51% ± 24% | |
| oligodendrocyte | 4 studies | 30% ± 8% | |
| fibroblast | 3 studies | 25% ± 3% | |
| abnormal cell | 3 studies | 25% ± 10% | |
| glial cell | 3 studies | 32% ± 18% | |
| Mueller cell | 3 studies | 34% ± 8% |
Insufficient scRNA-seq data for expression of COL9A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 3555.43 | 2529 / 2642 | 87% | 28.07 | 611 / 705 |
| intestine | 82% | 1472.80 | 796 / 966 | 64% | 16.28 | 336 / 527 |
| thymus | 90% | 4554.52 | 586 / 653 | 47% | 98.57 | 286 / 605 |
| skin | 39% | 263.74 | 711 / 1809 | 79% | 57.22 | 371 / 472 |
| pancreas | 61% | 762.32 | 200 / 328 | 47% | 7.39 | 83 / 178 |
| esophagus | 64% | 963.47 | 925 / 1445 | 38% | 12.28 | 70 / 183 |
| bladder | 52% | 401.81 | 11 / 21 | 40% | 6.71 | 204 / 504 |
| stomach | 31% | 348.62 | 112 / 359 | 48% | 22.42 | 138 / 286 |
| breast | 45% | 472.86 | 207 / 459 | 34% | 11.27 | 378 / 1118 |
| eye | 0% | 0 | 0 / 0 | 73% | 32.46 | 58 / 80 |
| prostate | 53% | 519.32 | 130 / 245 | 17% | 0.82 | 83 / 502 |
| uterus | 17% | 141.15 | 29 / 170 | 35% | 17.96 | 162 / 459 |
| ovary | 19% | 166.21 | 34 / 180 | 30% | 7.43 | 127 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 48% | 6.93 | 14 / 29 |
| heart | 46% | 441.54 | 394 / 861 | 0% | 0 | 0 / 0 |
| liver | 11% | 70.19 | 25 / 226 | 25% | 3.87 | 100 / 406 |
| spleen | 27% | 178.95 | 66 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 27% | 247.53 | 253 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 7% | 191.90 | 19 / 258 | 19% | 2.00 | 43 / 230 |
| lung | 1% | 25.89 | 8 / 578 | 24% | 5.05 | 273 / 1155 |
| kidney | 15% | 102.08 | 13 / 89 | 7% | 1.30 | 64 / 901 |
| adipose | 16% | 124.19 | 195 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 6.93 | 6 / 45 |
| blood vessel | 10% | 103.62 | 137 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 2.52 | 4 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005594 | Cellular component | collagen type IX trimer |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| Gene name | COL9A3 |
| Protein name | Collagen alpha-3(IX) chain Collagen type IX alpha 3 chain |
| Synonyms | |
| Description | FUNCTION: Structural component of hyaline cartilage and vitreous of the eye. |
| Accessions | Q4VXW1 Q14050 ENST00000649368.1 ENST00000452372.2 |
